Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 06, 2025
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 06, 2025
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.
Journal: Infectious diseases and therapy
Published: November 13, 2023
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
Journal: The New England journal of medicine
Published: March 23, 2022
Showing 1-4 of 4
Last Updated: 09/26/2026